Literature DB >> 19131776

Prevalence of multiple health-related behaviors in adolescents with cancer.

Melissa Y Carpentier1, Larry L Mullins, T David Elkin, Cortney Wolfe-Christensen.   

Abstract

OBJECTIVE: This preliminary study investigated prevalence rates of multiple health-related behaviors (ie, tobacco, alcohol, and other drug use; sexual risk-taking; nutrition/physical activity; overweight and dietary behaviors; sun safety) among 42 adolescents on active treatment for cancer, as compared with healthy adolescent norms.
METHODS: Health-related behaviors were assessed using the 2005 National Youth Risk Behavior Survey, for which healthy adolescent norms were publicly available.
RESULTS: Adolescents with cancer reported significantly lower current and lifetime rates of tobacco, alcohol, and other drug use; fruit/vegetable consumption; physical activity; and dietary behavior, in addition to lower rates of lifetime sexual intercourse, early-onset sexual intercourse, and alcohol/drug use before last sexual intercourse, compared with healthy peers. Among those who have previously engaged in sexual intercourse, there appeared to be a trend toward increased partners, current sexual activity, and lack of protection at last episode of sexual intercourse. Adolescents with cancer also reported significantly higher rates of television watching compared with healthy peers.
CONCLUSIONS: Adolescents on active treatment for cancer are engaging in multiple health-risk behaviors, including sedentary behavior, poor nutrition, lack of sun safety, and sexual risk-taking (eg, multiple partners, lack of protection at last sexual intercourse). Health promotion interventions are needed during active treatment to facilitate the acquisition of good health practices as adolescents transition into survivorship.

Entities:  

Mesh:

Year:  2008        PMID: 19131776     DOI: 10.1097/MPH.0b013e318186533f

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  7 in total

1.  Sexual Activity and Substance Use Among Adolescents and Young Adults Receiving Cancer Treatment: A Report from the PRISM Randomized Controlled Trial.

Authors:  Kaitlyn M Fladeboe; Samantha Scott; Miranda C Bradford; Tyler G Ketterl; Joyce P Yi-Frazier; Abby R Rosenberg
Journal:  J Adolesc Young Adult Oncol       Date:  2020-04-21       Impact factor: 2.223

2.  Low rates of pregnancy screening in adolescents before teratogenic exposures in a national sample of children's hospitals.

Authors:  Pooja Rao; Yimei Li; Kelly D Getz; Tamara P Miller; Yuan-Shung Huang; Jennifer J Wilkes; Alix E Seif; Rochelle Bagatell; Brian T Fisher; Clarisa Gracia; Richard Aplenc
Journal:  Cancer       Date:  2016-09-12       Impact factor: 6.860

3.  Providers' Perspectives on Addressing Health Risk Behaviors and Mental Health among Young Adult Survivors of Childhood Cancer.

Authors:  Carla J Berg; Erin Stratton; Natia Esiashvili; Ann Mertens; Robin C Vanderpool
Journal:  Am J Clin Cancer Res       Date:  2015-06-04

4.  Exploratory Analyses of Substance Use in Adolescents With and Without Cancer.

Authors:  Dava E Szalda; Lauren D Brumley; Carla K Danielson; Lisa A Schwartz
Journal:  J Adolesc Young Adult Oncol       Date:  2013-06       Impact factor: 2.223

5.  Risky health behavior among adolescents in the childhood cancer survivor study cohort.

Authors:  James L Klosky; Carrie R Howell; Zhenghong Li; Rebecca H Foster; Ann C Mertens; Leslie L Robison; Kirsten K Ness
Journal:  J Pediatr Psychol       Date:  2012-03-16

Review 6.  Quality of life in adolescent and young adult cancer patients: a systematic review of the literature.

Authors:  Gwendolyn P Quinn; Vânia Gonçalves; Ivana Sehovic; Meghan L Bowman; Damon R Reed
Journal:  Patient Relat Outcome Meas       Date:  2015-02-17

7.  Contraception Counseling and Use Among Adolescent and Young Adult Female Patients Undergoing Cancer Treatment: A Retrospective Analysis.

Authors:  Sarah H Abelman; Julia Cron
Journal:  J Pediatr Adolesc Gynecol       Date:  2020-10-01       Impact factor: 1.814

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.